IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient

Science Translational Medicine

Volumn 2, Issue 60, 2010, Pages

  Broadhurst, Mara J ^a   Leung, Jacqueline M ^b   Kashyap, Vikram ^b   McCune, Joseph M ^a   Mahadevan, Uma ^c   McKerrow, James H ^c   Loke, P'ng ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETAMIDOSALICYLIC ACID; INTERLEUKIN 13 RECEPTOR ALPHA2; INTERLEUKIN 17; INTERLEUKIN 22; MERCAPTOPURINE; MESALAZINE; STEROID; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CASE REPORT; CD4+ T LYMPHOCYTE; CELL HYPERPLASIA; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG MEGADOSE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GOBLET CELL; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; LAMINA PROPRIA; LIPID METABOLISM; MALE; MICROBIAL COLONIZATION; MOLECULAR DYNAMICS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REMISSION; TRICHURIASIS; ULCERATIVE COLITIS; UPREGULATION; ANIMAL; CLUSTER ANALYSIS; GENETIC MARKER; GENETICS; IMMUNOLOGY; MICROARRAY ANALYSIS; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; TRICHURIS;

ADULT; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CLUSTER ANALYSIS; COLITIS, ULCERATIVE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; INTERLEUKINS; INTESTINAL MUCOSA; MALE; MICROARRAY ANALYSIS; TRICHURIASIS; TRICHURIS;

EID: 78649823511     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3001500     Document Type: Article

References (46)

1. R. J. Xavier, D. K. Podolsky, Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
2. D. R. Littman, A. Y. Rudensky, Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858 (2010).
3. E. V. Loftus Jr., Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517 (2004).
4. N. R. de Silva, S. Brooker, P. J. Hotez, A. Montresor, D. Engels, L. Savioli, Soil-transmitted helminth infections: Updating the global picture. Trends Parasitol. 19, 547-551 (2003).
5. R. M. Maizels, M. Yazdanbakhsh, Immune regulation by helminth parasites: Cellular and molecular mechanisms. Nat. Rev. Immunol. 3, 733-744 (2003).
6. D. E. Elliott, R. W. Summers, J. V. Weinstock, Helminths as governors of immune-mediated inflammation. Int. J. Parasitol. 37, 457-464 (2007).
7. R. W. Summers, D. E. Elliott, J. F. Urban Jr., R. A. Thompson, J. V. Weinstock, Trichuris suis therapy for active ulcerative colitis: A randomized controlled trial. Gastroenterology 128, 825-832 (2005).
8. R. W. Summers, D. E. Elliott, J. F. Urban Jr., R. A. Thompson, J. V. Weinstock, Trichuris suis therapy in Crohn's disease. Gut 54, 87-90 (2005).
9. L. R. Schopf, K. F. Hoffmann, A. W. Cheever, J. F. Urban Jr., T. A. Wynn, IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. J. Immunol. 168, 2383-2392 (2002).
10. 2-mediated attenuation of IL-13 activity. Gastroenterology 10.1053/j.gastro.2010.09.047 (2010).
11. T. A. Wynn, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J. Clin. Invest. 117, 524-529 (2007).
12. S. Eyerich, K. Eyerich, A. Cavani, C. Schmidt-Weber, IL-17 and IL-22: Siblings, not twins. Trends Immunol. 31, 354-361 (2010).
13. G. Pickert, C. Neufert, M. Leppkes, Y. Zheng, N. Wittkopf, M. Warntjen, H. A. Lehr, S. Hirth, B. Weigmann, S. Wirtz, W. Ouyang, M. F. Neurath, C. Becker, STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009).
14. Y. Zheng, P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, W. Ouyang, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282-289 (2008).
15. M. Cella, A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, M. Colonna, A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
16. S. C. Liang, X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, L. A. Fouser, Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
17. K. Sugimoto, A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A. K. Bhan, R. S. Blumberg, R. J. Xavier, A. Mizoguchi, IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008).
18. L. A. Zenewicz, G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, S. Stevens, R. A. Flavell, Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
19. H2 cells. Nat. Immunol. 10, 864-871 (2009).
20. T. Duhen, R. Geiger, D. Jarrossay, A. Lanzavecchia, F. Sallusto, Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 10, 857-863 (2009).
21. D. W. Compton, How much human helminthiasis is there in the world? J. Parasitol. 85, 397-403 (1999).
22. S. M. Wilhelm, K. A. McKenney, K. N. Rivait, P. B. Kale-Pradhan, A review of infliximab use in ulcerative colitis. Clin. Ther. 30, 223-230 (2008).
23. + T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 125, 222-230.e4 (2010).
24. P. Loke, D. Favre, P. W. Hunt, J. M. Leung, B. Kanwar, J. N. Martin, S. G. Deeks, J. M. McCune, Correlating cellular and molecular signatures of mucosal immunity that distinguish HIV controllers from noncontrollers. Blood 115, e20-e32 (2010).
25. D. Artis, R. K. Grencis, The intestinal epithelium: Sensors to effectors in nematode infection. Mucosal Immunol. 1, 252-264 (2008).
26. P. R. Gibson, J. G. Muir, Reinforcing the mucus: A new therapeutic approach for ulcerative colitis? Gut 54, 900-903 (2005).
27. K. Kyo, T. Muto, H. Nagawa, G. M. Lathrop, Y. Nakamura, Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease. J. Hum. Genet. 46, 5-20 (2001).
28. K. Kyo, M. Parkes, Y. Takei, H. Nishimori, P. Vyas, J. Satsangi, J. Simmons, H. Nagawa, S. Baba, D. Jewell, T. Muto, G. M. Lathrop, Y. Nakamura, Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3. Hum. Mol. Genet. 8, 307-311 (1999).
29. M. Van der Sluis, B. A. De Koning, A. C. De Bruijn, A. Velcich, J. P. Meijerink, J. B. Van Goudoever, H. A. Büller, J. Dekker, I. Van Seuningen, I. B. Renes, A. W. Einerhand, Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117-129 (2006).
30. G. An, B. Wei, B. Xia, J. M. McDaniel, T. Ju, R. D. Cummings, J. Braun, L. Xia, Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med. 204, 1417-1429 (2007).
31. C. K. Heazlewood, M. C. Cook, R. Eri, G. R. Price, S. B. Tauro, D. Taupin, D. J. Thornton, C. W. Png, T. L. Crockford, R. J. Cornall, R. Adams, M. Kato, K. A. Nelms, N. A. Hong, T. H. Florin, C. C. Goodnow, M. A. McGuckin, Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med. 5, e54 (2008).
32. W. Stremmel, U. Merle, A. Zahn, F. Autschbach, U. Hinz, R. Ehehalt, Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis. Gut 54, 966-971 (2005).
33. W. Stremmel, A. Braun, A. Hanemann, R. Ehehalt, F. Autschbach, M. Karner, Delayed release phosphatidylcholine in chronic-active ulcerative colitis: A randomized, double-blinded, dose finding study. J. Clin. Gastroenterol. 44, e101-e107 (2010).
34. I. J. Fuss, W. Strober, The role of IL-13 and NK T cells in experimental and human ulcerative colitis. Mucosal Immunol. 1 (Suppl. 1), S31-S33 (2008).
35. P. von Stein, R. Lofberg, N. V. Kuznetsov, A. W. Gielen, J. O. Persson, R. Sundberg, K. Hellstrom, A. Eriksson, R. Befrits, A. Ost, O. D. von Stein, Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome. Gastroenterology 134, 1869-1881 (2008).
36. I. Arijs, K. Li, G. Toedter, R. Quintens, L. Van Lommel, K. Van Steen, P. Leemans, G. De Hertogh, K. Lemaire, M. Ferrante, F. Schnitzler, L. Thorrez, K. Ma, X. Y. Song, C. Marano, G. Van Assche, S. Vermeire, K. Geboes, F. Schuit, F. Baribaud, P. Rutgeerts, Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut 58, 1612-1619 (2009).
37. 2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 135, 2003-2013 (2008).
38. 1 production and fibrosis. Nat. Med. 12, 99-106 (2006).
39. E. Mizoguchi, Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing bacterial adhesion and invasion in colonic epithelial cells. Gastroenterology 130, 398-411 (2006).
40. C. Ober, G. L. Chupp, The chitinase and chitinase-like proteins: A review of genetic and functional studies in asthma and immune-mediated diseases. Curr. Opin. Allergy Clin. Immunol. 9, 401-408 (2009).
41. D. Artis, M. L. Wang, S. A. Keilbaugh, W. He, M. Brenes, G. P. Swain, P. A. Knight, D. D. Donaldson, M. A. Lazar, H. R. Miller, G. A. Schad, P. Scott, G. D. Wu, RELMβ/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. U.S.A. 101, 13596-13600 (2004).
42. D. R. Herbert, J. Q. Yang, S. P. Hogan, K. Groschwitz, M. Khodoun, A. Munitz, T. Orekov, C. Perkins, Q. Wang, F. Brombacker, J. F. Urban Jr., M. E. Rothenberg, F. D. Finkelman, Intestinal epithelial cell secretion of RELM-β protects against gastrointestinal worm infection. J. Exp. Med. 206, 2947-2957 (2009).
43. R. B. Krimi, L. Kotelevets, L. Dubuquoy, P. Plaisancié, F. Walker, T. Lehy, P. Desreumaux, I. Van Seuningen, E. Chastre, M. E. Forgue-Lafitte, J. C. Marie, Resistin-like molecule β regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm. Bowel Dis. 14, 931-941 (2008).
44. http://alizadehlab.stanford.edu/.
45. V. G. Tusher, R. Tibshirani, G. Chu, Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98, 5116-5121 (2001).
46. P. D. Thomas, M. J. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman, K. Diemer, A. Muruganujan, A. Narechania, PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 13, 2129-2141 (2003).